137 related articles for article (PubMed ID: 20432813)
1. Changes of dipeptidyl peptidase IV (DPP-IV) in obese children with weight loss: relationships to peptide YY, pancreatic peptide, and insulin sensitivity.
Reinehr T; Roth CL; Enriori PJ; Masur K
J Pediatr Endocrinol Metab; 2010; 23(1-2):101-8. PubMed ID: 20432813
[TBL] [Abstract][Full Text] [Related]
2. Short-term aerobic exercise training increases postprandial pancreatic polypeptide but not peptide YY concentrations in obese individuals.
Kanaley JA; Heden TD; Liu Y; Whaley-Connell AT; Chockalingam A; Dellsperger KC; Fairchild TJ
Int J Obes (Lond); 2014 Feb; 38(2):266-71. PubMed ID: 23736355
[TBL] [Abstract][Full Text] [Related]
3. Pancreatic polypeptide in obese children before and after weight loss.
Reinehr T; Enriori PJ; Harz K; Cowley MA; Roth CL
Int J Obes (Lond); 2006 Oct; 30(10):1476-81. PubMed ID: 16702998
[TBL] [Abstract][Full Text] [Related]
4. Lower dipeptidyl peptidase-4 following exercise training plus weight loss is related to increased insulin sensitivity in adults with metabolic syndrome.
Malin SK; Huang H; Mulya A; Kashyap SR; Kirwan JP
Peptides; 2013 Sep; 47():142-7. PubMed ID: 23872069
[TBL] [Abstract][Full Text] [Related]
5. The effect of meal frequency in a reduced-energy regimen on the gastrointestinal and appetite hormones in patients with type 2 diabetes: A randomised crossover study.
Belinova L; Kahleova H; Malinska H; Topolcan O; Windrichova J; Oliyarnyk O; Kazdova L; Hill M; Pelikanova T
PLoS One; 2017; 12(4):e0174820. PubMed ID: 28369078
[TBL] [Abstract][Full Text] [Related]
6. Peptide YY(1-36) and peptide YY(3-36): Part II. Changes after gastrointestinal surgery and bariatric surgery.
Ballantyne GH
Obes Surg; 2006 Jun; 16(6):795-803. PubMed ID: 16756746
[TBL] [Abstract][Full Text] [Related]
7. Peptide YY(1-36) and peptide YY(3-36): Part I. Distribution, release and actions.
Ballantyne GH
Obes Surg; 2006 May; 16(5):651-8. PubMed ID: 16687037
[TBL] [Abstract][Full Text] [Related]
8. Children with Prader-Willi syndrome exhibit more evident meal-induced responses in plasma ghrelin and peptide YY levels than obese and lean children.
Bizzarri C; Rigamonti AE; Luce A; Cappa M; Cella SG; Berini J; Sartorio A; Müller EE; Salvatoni A
Eur J Endocrinol; 2010 Mar; 162(3):499-505. PubMed ID: 20019130
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic polypeptide meal response may predict gastric band-induced weight loss.
Dixon AF; le Roux CW; Ghatei MA; Bloom SR; McGee TL; Dixon JB
Obes Surg; 2011 Dec; 21(12):1906-13. PubMed ID: 21710297
[TBL] [Abstract][Full Text] [Related]
10. Relation of fasting plasma peptide YY to glucose metabolism and cardiovascular risk factors after restrictive bariatric surgery.
Hanusch-Enserer U; Ghatei MA; Cauza E; Bloom SR; Prager R; Roden M
Wien Klin Wochenschr; 2007; 119(9-10):291-6. PubMed ID: 17571233
[TBL] [Abstract][Full Text] [Related]
11. Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents.
Stock S; Leichner P; Wong AC; Ghatei MA; Kieffer TJ; Bloom SR; Chanoine JP
J Clin Endocrinol Metab; 2005 Apr; 90(4):2161-8. PubMed ID: 15657373
[TBL] [Abstract][Full Text] [Related]
12. Peptide YY is a regulator of energy homeostasis in obese children before and after weight loss.
Roth CL; Enriori PJ; Harz K; Woelfle J; Cowley MA; Reinehr T
J Clin Endocrinol Metab; 2005 Dec; 90(12):6386-91. PubMed ID: 16204364
[TBL] [Abstract][Full Text] [Related]
13. Fasting glucagon-like peptide-1 and its relation to insulin in obese children before and after weight loss.
Reinehr T; de Sousa G; Roth CL
J Pediatr Gastroenterol Nutr; 2007 May; 44(5):608-12. PubMed ID: 17460495
[TBL] [Abstract][Full Text] [Related]
14. Lower plasma levels of glucose-dependent insulinotropic peptide (GIP) and pancreatic polypeptide (PP) in patients with ductal adenocarcinoma of the pancreas and their relation to the presence of impaired glucoregulation and weight loss.
Škrha J; Bušek P; Uhrová J; Hrabal P; Kmochová K; Laclav M; Bunganič B; Frič P
Pancreatology; 2017; 17(1):89-94. PubMed ID: 28027898
[TBL] [Abstract][Full Text] [Related]
15. Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss.
Valderas JP; Irribarra V; Boza C; de la Cruz R; Liberona Y; Acosta AM; Yolito M; Maiz A
J Clin Endocrinol Metab; 2010 Mar; 95(3):1069-75. PubMed ID: 20097707
[TBL] [Abstract][Full Text] [Related]
16. Altered distribution of adiponectin isoforms in children with Prader-Willi syndrome (PWS): association with insulin sensitivity and circulating satiety peptide hormones.
Haqq AM; Muehlbauer M; Svetkey LP; Newgard CB; Purnell JQ; Grambow SC; Freemark MS
Clin Endocrinol (Oxf); 2007 Dec; 67(6):944-51. PubMed ID: 17666087
[TBL] [Abstract][Full Text] [Related]
17. Obese patients have higher circulating protein levels of dipeptidyl peptidase IV.
Stengel A; Goebel-Stengel M; Teuffel P; Hofmann T; Buße P; Kobelt P; Rose M; Klapp BF
Peptides; 2014 Nov; 61():75-82. PubMed ID: 25219943
[TBL] [Abstract][Full Text] [Related]
18. Serum peptide YY in response to short-term overfeeding in young men.
Cahill F; Shea JL; Randell E; Vasdev S; Sun G
Am J Clin Nutr; 2011 Apr; 93(4):741-7. PubMed ID: 21289220
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide 1 (GLP-1) secretion and plasma dipeptidyl peptidase IV (DPP-IV) activity in morbidly obese patients undergoing biliopancreatic diversion.
Lugari R; Dei Cas A; Ugolotti D; Barilli AL; Camellini C; Ganzerla GC; Luciani A; Salerni B; Mittenperger F; Nodari S; Gnudi A; Zandomeneghi R
Horm Metab Res; 2004 Feb; 36(2):111-5. PubMed ID: 15002062
[TBL] [Abstract][Full Text] [Related]
20. Laparoscopic sleeve gastrectomy differentially affects serum concentrations of FGF-19 and FGF-21 in morbidly obese subjects.
Haluzíková D; Lacinová Z; Kaválková P; Drápalová J; Křížová J; Bártlová M; Mráz M; Petr T; Vítek L; Kasalický M; Haluzík M
Obesity (Silver Spring); 2013 Jul; 21(7):1335-42. PubMed ID: 23670968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
